Biomarkers Market to Surpass US$ 60 Billion By 2023

New York, December 26, 2018: The scope of the report includes a detailed study of global and regional markets for various types of biomarkers market with the reasons given for variations in the growth of the industry in certain regions.

Biomarkers are biological measures used to measure biological states such as blood pressure, cholesterol level and monitor and forecast health level of individual. Biomarkers are used in single or in combination to identify health or disease of individual. Different varieties of biomarkers are used currently for various applications. Every biological system consists of its own biomarkers. Some biomarkers are easy to use, measure and form part of routine medical examinations. Biomarkers are used to estimate health and disease of individual such as diabetes and cardiovascular. Biomarkers are used for detection, screening, diagnosis, treatment and monitoring of cancer.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include QIAGEN N.V. (Netherlands), PerkinElmer, Inc., Merck & Co, Inc., Bio-Rad Laboratories , Enzo Biochem , EKF Diagnostics Holdings plc , Meso Scale Diagnostics, LLC , Singulex, Inc. , BioSims Technologies , Cisbio Bioassays , and Signosis, Inc.. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

You Can Find Full Report @: https://www.marketresearchengine.com/reportdetails/biomarkers-market

This report provides:

1) An overview of the global market for biomarkers and related technologies.

2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2023.

3) Identifications of new market opportunities and targeted promotional plans for biomarkers.

4) Discussion of research and development, and the demand for new products and new applications.

5) Comprehensive company profiles of major players in the industry.

The Biomarkers market is expected to exceed more than US$ 60.0 billion by 2023 growing at around 13% CAGR.

The Biomarkers Market has been segmented as below:

The Biomarkers Market is Segmented on the lines of Product Segment Analysis, Type Analysis, Application Analysis, Disease Indication Analysis and Regional Analysis. By Product Segment Analysis this market is segmented on the basis of Consumable, Services and

Software. By Type Analysis this market is segmented on the basis of Safety biomarker, Efficacy biomarker and Validation biomarker.

By Application Analysis this market is segmented on the basis of Diagnostics development, Drug discovery & development, Personalized medicine and Disease risk assessment. By Disease Indication Analysis this market is segmented on the basis of Cancer, Cardiovascular disorders, Neurological disorders and Immunological disorders. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

Market Research Engine has published a new report titled as “Biomarkers Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2023”.

Request Sample Report from here: https://www.marketresearchengine.com/reportdetails/biomarkers-market

Table of Contents

1 INTRODUCTION

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Biomarkers: Market Overview
4.2 Geographic Analysis: Biomarkers Market, By Product (2016)
4.3 Market, By Type, 2016 vs 2021
4.4 Market Size, By Application, 2016 vs 2021
4.5 Market, By Disease Indication, 2016 vs 2021
4.6 Market: Geographic Growth Opportunities
4.7 Life Cycle Analysis, By Region, 2016

5 Market Overview

6 Biomarkers Market, By Product

7 Biomarkers Market, By Type

8 Biomarkers Market, By Application

9 Biomarkers Market, By Disease Indication

10 Biomarkers Market, By Region

11 Competitive Landscape

12 Company Profiles

12.1 Qiagen N.V.

12.2 Perkinelmer, Inc.

12.3 Merck Millipore

12.4 Bio-Rad Laboratories, Inc.

12.5 Enzo Biochem, Inc.

12.6 EKF Diagnostics Holdings, Inc.

12.7 Meso Scale Diagnostics, LLC.

12.8 Biosims Technologies Sas

12.9 Cisbio Bioassays

12.10 Signosis, Inc.

Other Related Market Research Reports:

Bio Bank Market Size is Projected to be Around US$ 760 Million By 2022

Bleeding Disorders Treatment Market Size is Projected to be Around US$ 14.50 Billion By 2022

Cancer Immunotherapy Market Size is Projected to be Around US$ 145 Billion By 2024

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

The post Biomarkers Market to Surpass US$ 60 Billion By 2023 appeared first on Herald Keeper.

Add Comment